ARCA Biopharma Inc

Company Profile

ARCA Biopharma Inc had its IPO on 1997-08-08 under the ticker symbol ABIO.

The company operates in the Healthcare sector and Biotechnology industry. ARCA Biopharma Inc has a staff strength of 5 employees.

Stock update

Shares of ARCA Biopharma Inc opened at $2.02 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $2.02 - $2.05, and closed at $2.03.

This is a -0.98% slip from the previous day's closing price.

A total volume of 17,310 shares were traded at the close of the day’s session.

In the last one week, shares of ARCA Biopharma Inc have slipped by -1.46%.

ARCA Biopharma Inc's Key Ratios

ARCA Biopharma Inc has a market cap of $31.56 million, indicating a price to book ratio of 0.769 and a price to sales ratio of 0.

In the last 12-months ARCA Biopharma Inc’s revenue was $0 with a gross profit of $0 and an EBITDA of $-9821000. The EBITDA ratio measures ARCA Biopharma Inc's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, ARCA Biopharma Inc’s operating margin was 0% while its return on assets stood at -12.55% with a return of equity of -21.41%.

In Q4, ARCA Biopharma Inc’s quarterly earnings growth was a positive 0% while revenue growth was a positive 0%.

ARCA Biopharma Inc’s PE and PEG Ratio

Forward PE

0

Trailing PE

0

PEG

0

Its diluted EPS in the last 12-months stands at $-0.68 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of 0. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into ARCA Biopharma Inc’s profitability.

ARCA Biopharma Inc stock is trading at a EV to sales ratio of 0 and a EV to EBITDA ratio of 0.7385. Its price to sales ratio in the trailing 12-months stood at 0.

ARCA Biopharma Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets

$43.09 million

Total Liabilities

$1.13 million

Operating Cash Flow

$0

Capital Expenditure

$0

Dividend Payout Ratio

0%

ARCA Biopharma Inc ended 2024 with $43.09 million in total assets and $0 in total liabilities. Its intangible assets were valued at $43.09 million while shareholder equity stood at $41.67 million.

ARCA Biopharma Inc ended 2024 with $0 in deferred long-term liabilities, $1.13 million in other current liabilities, 14000.00 in common stock, $-183402000.00 in retained earnings and $0 in goodwill. Its cash balance stood at $42.45 million and cash and short-term investments were $42.45 million. The company’s total short-term debt was $0 while long-term debt stood at $0.

ARCA Biopharma Inc’s total current assets stands at $42.70 million while long-term investments were $0 and short-term investments were $0. Its net receivables were $0 compared to accounts payable of $334000.00 and inventory worth $0.

In 2024, ARCA Biopharma Inc's operating cash flow was $0 while its capital expenditure stood at $0.

Comparatively, ARCA Biopharma Inc paid $0 in dividends in 2024.

Other key metrics

Current Trading Price

$2.03

52-Week High

$2.7

52-Week Low

$1.7645

Analyst Target Price

$

ARCA Biopharma Inc stock is currently trading at $2.03 per share. It touched a 52-week high of $2.7 and a 52-week low of $2.7. Analysts tracking the stock have a 12-month average target price of $.

Its 50-day moving average was $2.04 and 200-day moving average was $2.12 The short ratio stood at 9.07 indicating a short percent outstanding of 0%.

Around 102.1% of the company’s stock are held by insiders while 4591.4% are held by institutions.